ENTITY
Pacific Edge

Pacific Edge (PEB NZ)

52
Analysis
Health CareNew Zealand
Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.
more
bearishPacific Edge
10 Oct 2024 08:23Broker

Pacific Edge - Consolidation Mode

Pacific Edge's (PEB) 2Q25 update showed expected softness in lab throughput trends. 2Q25 tests of 7,045 was down -17% versus 2Q24, and slightly...

Logo
263 Views
Share
bullishPacific Edge
22 May 2024 06:39Broker

Pacific Edge - FY24 Result — Stuck in Neutral

NEUTRAL rating given the LCD outcome is binary and therefore high-risk, lab throughput is subdued, and under any scenario the risk of an equity...

Logo
246 Views
Share
bullishPacific Edge
10 Apr 2024 07:02Broker

Pacific Edge - 4Q24 — Battening Down the Hatches

Pacific Edge's (PEB) 4Q24 update all but confirmed the halt in momentum, with lab throughput down -19% versus 4Q23 and broadly flat versus 3Q24

Logo
314 Views
Share
bullishPacific Edge
23 Jan 2024 07:05Broker

Pacific Edge - 3Q24 — Cost and Revenue Decline

Pacific Edge's (PEB) 3Q24 update highlights ongoing softness in lab throughput with -8% year on year and -16% sequential declines as it reduces its...

Logo
229 Views
Share
bearishPacific Edge
29 Dec 2023 07:59Broker

Pacific Edge - Rubber Approaching the Road

Pacific Edge’s (PEB) 2Q24 test volumes highlighted slowing momentum with +8% year on year growth and a -12% sequential decline.

Logo
490 Views
Share
x